Medical and Pharmaceutical bioAffinity jumps 45% from lung cancer phlegm test expansion It is the only commercially available test of its kind Rowan Dunne8 hours ago
Medical and Pharmaceutical Revolution’s newly approved drug doubles pancreatic cancer survival time A 30-day course of Rasonque costs US$39,800 Rowan Dunne2 days ago
Medical and Pharmaceutical Freenome gets FDA breakthrough designation for ‘SimpleScreen’ lung cancer blood test Achievement builds on firm securing agency's approval for a colorectal cancer test variation Rowan DunneAugust 13, 2026
Medical and Pharmaceutical Sionna shares plummet after cystic fibrosis clinical trial failure The 92% plunge has been beneficial for competitor Vertex Pharma Rowan DunneAugust 11, 2026
Medical and Pharmaceutical Replimune tanks on FDA concerns about its skin cancer therapy Shares slid by more than 37% at the intraday low on Tuesday Rowan DunneJuly 29, 2026
Medical and Pharmaceutical CNS drug specialist Jupiter Neuro signs MDMA deal with PharmAla Biotech The pivotal agreement is valued at up to US$100 million Rowan DunneJuly 22, 2026
Psychedelics Pharma giant Eli Lilly enters psychedelics space with AtaiBeckley takeover AtaiBeckley stock rose more than 55% in after-hours trading Wednesday Rowan DunneJuly 16, 2026
Psychedelics Definium Therapeutics soars on Phase 3 trial win with LSD depression drug The rally follows year-to-date gains of nearly 175% Rowan DunneJune 24, 2026
Psychedelics Psilera raises US$8.8M to fight dementia with non-psychoactive psilocybin drug The biotech is preparing for in-human trials with 'PSIL-006' next year Rowan DunneMay 29, 2026
Medical and Pharmaceutical CNS Pharma sees 250% spike from oversubscribed private placement The oncology and biotech firm has secured approximately US$22.5 million Rowan DunneMay 5, 2026